13 November 2024 - NICE has published final evidence-based recommendations on the use of alectinib hydrochloride for the adjuvant treatment ...
12 November 2024 - PHARMAC has decided to fund the medicine empagliflozin for thousands of people with a type of ...
11 November 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
11 November 2024 - PHARMAC will make two changes for people with attention deficit hyperactivity disorder (ADHD) and narcolepsy this ...
10 November 2024 - Australian mums and their newborn babies will have free access to the best and most comprehensive ...
10 November 2024 - Labor has failed to plan for the consequences of delaying drug subsidies and left hundreds of ...
8 November 2024 - Merck announced that Canada's Drug Agency has recommended Winrevair (sotatercept) for reimbursement in combination with standard ...
8 November 2024 - Fears of on-going delays to critical new medicine subsidies have been stoked by a Health Department ...
6 November 2024 - The Albanese Government is ensuring patients get access to life changing medications and treatments as quickly ...
8 November 2024 - PHARMAC has decided to fund lenvatinib from 1 December 2024 for people with some types of ...
6 November 2024 - Health Minister Mark Butler has directed the PBAC to hold an unprecedented extra meeting, after the ...
6 November 2024 - PHARMAC has published the agenda for the upcoming 14-15 November 2024 PTAC meeting. ...
6 November 2024 - NICE has published evidence-based recommendations on the use of avapritinib (Ayvakyt) for the treatment of adults ...
5 November 2024 - Pharmaceutical companies whose medicines have been indefinitely delayed are being charged $200,000 per application despite no services ...
5 November 2024 - Following an appeal, NICE has published further draft guidance on the use of using fenfluramine hydrochloride ...